Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice

Fernando DeMiguel, Soo Ok Lee, Wei Lou, Xiao Xiao, Beth Pflug, Joel B. Nelson, Allen C. Gao

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

BACKGROUND. Prostate cancer frequently progresses from an initial androgen dependence to androgen independence, rendering the only effective androgen ablation therapy useless. The mechanism underlying the androgen-independent progression is unknown. Stat3, a member of the family of signal transducers and activators of transcription, is activated in numerous cancers, including prostate. This study is to investigate the role of Stat3 activation in the growth of prostate cancer cells. METHODS. A constitutively active Stat3 was ectopically expressed in androgen-sensitive LNCaP prostate cancer cells and resulting stable clones expressing activated Stat3 were isolated. The effect of Stat3 activation on LNCaP cell growth in response to androgen in vitro and in vivo was examined. RESULTS. We show that the levels of activated Stat3 are associated with the progression of androgen-independent prostate cancer. Activation of Stat3 in androgen-sensitive LNCaP prostate cancer cells results in enhancement of tumor growth in both intact and castrated male nude mice and enhances androgen receptor-mediated prostate specific antigen expression. CONCLUSIONS. These findings demonstrate that intracellular signaling mediated by Stat3 can enhance the growth of androgen-sensitive human LNCaP prostate cancer cells in both intact and castrated male nude mice.

Original languageEnglish (US)
Pages (from-to)123-129
Number of pages7
JournalProstate
Volume52
Issue number2
DOIs
StatePublished - Jun 1 2002
Externally publishedYes

Fingerprint

Nude Mice
Androgens
Prostatic Neoplasms
Growth
Prostate-Specific Antigen
Transducers
Clone Cells

Keywords

  • Androgen receptor
  • Androgen-independence
  • Prostate cancer
  • Stat3

ASJC Scopus subject areas

  • Urology

Cite this

Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice. / DeMiguel, Fernando; Lee, Soo Ok; Lou, Wei; Xiao, Xiao; Pflug, Beth; Nelson, Joel B.; Gao, Allen C.

In: Prostate, Vol. 52, No. 2, 01.06.2002, p. 123-129.

Research output: Contribution to journalArticle

DeMiguel, Fernando ; Lee, Soo Ok ; Lou, Wei ; Xiao, Xiao ; Pflug, Beth ; Nelson, Joel B. ; Gao, Allen C. / Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice. In: Prostate. 2002 ; Vol. 52, No. 2. pp. 123-129.
@article{3965a08882334174b9b23ad54dcbe731,
title = "Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice",
abstract = "BACKGROUND. Prostate cancer frequently progresses from an initial androgen dependence to androgen independence, rendering the only effective androgen ablation therapy useless. The mechanism underlying the androgen-independent progression is unknown. Stat3, a member of the family of signal transducers and activators of transcription, is activated in numerous cancers, including prostate. This study is to investigate the role of Stat3 activation in the growth of prostate cancer cells. METHODS. A constitutively active Stat3 was ectopically expressed in androgen-sensitive LNCaP prostate cancer cells and resulting stable clones expressing activated Stat3 were isolated. The effect of Stat3 activation on LNCaP cell growth in response to androgen in vitro and in vivo was examined. RESULTS. We show that the levels of activated Stat3 are associated with the progression of androgen-independent prostate cancer. Activation of Stat3 in androgen-sensitive LNCaP prostate cancer cells results in enhancement of tumor growth in both intact and castrated male nude mice and enhances androgen receptor-mediated prostate specific antigen expression. CONCLUSIONS. These findings demonstrate that intracellular signaling mediated by Stat3 can enhance the growth of androgen-sensitive human LNCaP prostate cancer cells in both intact and castrated male nude mice.",
keywords = "Androgen receptor, Androgen-independence, Prostate cancer, Stat3",
author = "Fernando DeMiguel and Lee, {Soo Ok} and Wei Lou and Xiao Xiao and Beth Pflug and Nelson, {Joel B.} and Gao, {Allen C.}",
year = "2002",
month = "6",
day = "1",
doi = "10.1002/pros.10110",
language = "English (US)",
volume = "52",
pages = "123--129",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice

AU - DeMiguel, Fernando

AU - Lee, Soo Ok

AU - Lou, Wei

AU - Xiao, Xiao

AU - Pflug, Beth

AU - Nelson, Joel B.

AU - Gao, Allen C.

PY - 2002/6/1

Y1 - 2002/6/1

N2 - BACKGROUND. Prostate cancer frequently progresses from an initial androgen dependence to androgen independence, rendering the only effective androgen ablation therapy useless. The mechanism underlying the androgen-independent progression is unknown. Stat3, a member of the family of signal transducers and activators of transcription, is activated in numerous cancers, including prostate. This study is to investigate the role of Stat3 activation in the growth of prostate cancer cells. METHODS. A constitutively active Stat3 was ectopically expressed in androgen-sensitive LNCaP prostate cancer cells and resulting stable clones expressing activated Stat3 were isolated. The effect of Stat3 activation on LNCaP cell growth in response to androgen in vitro and in vivo was examined. RESULTS. We show that the levels of activated Stat3 are associated with the progression of androgen-independent prostate cancer. Activation of Stat3 in androgen-sensitive LNCaP prostate cancer cells results in enhancement of tumor growth in both intact and castrated male nude mice and enhances androgen receptor-mediated prostate specific antigen expression. CONCLUSIONS. These findings demonstrate that intracellular signaling mediated by Stat3 can enhance the growth of androgen-sensitive human LNCaP prostate cancer cells in both intact and castrated male nude mice.

AB - BACKGROUND. Prostate cancer frequently progresses from an initial androgen dependence to androgen independence, rendering the only effective androgen ablation therapy useless. The mechanism underlying the androgen-independent progression is unknown. Stat3, a member of the family of signal transducers and activators of transcription, is activated in numerous cancers, including prostate. This study is to investigate the role of Stat3 activation in the growth of prostate cancer cells. METHODS. A constitutively active Stat3 was ectopically expressed in androgen-sensitive LNCaP prostate cancer cells and resulting stable clones expressing activated Stat3 were isolated. The effect of Stat3 activation on LNCaP cell growth in response to androgen in vitro and in vivo was examined. RESULTS. We show that the levels of activated Stat3 are associated with the progression of androgen-independent prostate cancer. Activation of Stat3 in androgen-sensitive LNCaP prostate cancer cells results in enhancement of tumor growth in both intact and castrated male nude mice and enhances androgen receptor-mediated prostate specific antigen expression. CONCLUSIONS. These findings demonstrate that intracellular signaling mediated by Stat3 can enhance the growth of androgen-sensitive human LNCaP prostate cancer cells in both intact and castrated male nude mice.

KW - Androgen receptor

KW - Androgen-independence

KW - Prostate cancer

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=0036603046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036603046&partnerID=8YFLogxK

U2 - 10.1002/pros.10110

DO - 10.1002/pros.10110

M3 - Article

VL - 52

SP - 123

EP - 129

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 2

ER -